150 related articles for article (PubMed ID: 31407729)
1. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.
Yu Z; Fan W; Wang L; He H; Lv Y; Qi J; Lu Y; Wu W
Biomater Sci; 2019 Oct; 7(10):4273-4282. PubMed ID: 31407729
[TBL] [Abstract][Full Text] [Related]
2. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles.
Yu Z; Fan W; Wang L; Qi J; Lu Y; Wu W
Mol Pharm; 2019 Dec; 16(12):5013-5024. PubMed ID: 31638827
[TBL] [Abstract][Full Text] [Related]
3. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.
Hu X; Fan W; Yu Z; Lu Y; Qi J; Zhang J; Dong X; Zhao W; Wu W
Nanoscale; 2016 Apr; 8(13):7024-35. PubMed ID: 26725649
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.
Joyce P; Dening TJ; Meola TR; Gustafsson H; Kovalainen M; Prestidge CA
Eur J Pharm Sci; 2019 Jul; 135():1-11. PubMed ID: 31067495
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.
Shangguan M; Qi J; Lu Y; Wu W
Int J Pharm; 2015 Jul; 489(1-2):195-202. PubMed ID: 25956049
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).
Yadav M; Schiavone N; Guzman-Aranguez A; Giansanti F; Papucci L; Perez de Lara MJ; Singh M; Kaur IP
Drug Deliv Transl Res; 2020 Aug; 10(4):919-944. PubMed ID: 32270439
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
11. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
13. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF
Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878
[TBL] [Abstract][Full Text] [Related]
14. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
[TBL] [Abstract][Full Text] [Related]
15. In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract.
Jannin V; Dellera E; Chevrier S; Chavant Y; Voutsinas C; Bonferoni C; Demarne F
Drug Dev Ind Pharm; 2015; 41(10):1582-8. PubMed ID: 25342478
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
17. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation.
Piazzini V; Cinci L; D'Ambrosio M; Luceri C; Bilia AR; Bergonzi MC
Curr Drug Deliv; 2019; 16(2):142-152. PubMed ID: 30306869
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
Wang T; Ma X; Lei Y; Luo Y
Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]